Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2017-2028

2.1.2 Proprotein Convertase Subtilisin/Kexin Type 9 Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Proprotein Convertase Subtilisin/Kexin Type 9 Segment by Type

2.2.1 SX-PCK9

2.2.2 O-304

2.2.3 K-312

2.2.4 BLSM-201

2.2.5 DCRPCSK-9

2.2.6 Others

2.3 Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Type

2.3.1 Proprotein Convertase Subtilisin/Kexin Type 9 Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Type (2017-2022)

2.4 Proprotein Convertase Subtilisin/Kexin Type 9 Segment by Application

2.4.1 Cardiovascular Disease

2.4.2 Homozugous Familial Hyperchalesterolemia

2.4.3 Liver Disease

2.4.4 Metabolic Syndrome

2.4.5 Others

2.5 Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Application

2.5.1 Proprotein Convertase Subtilisin/Kexin Type 9 Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Application (2017-2022)

3 Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Player

3.1 Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Players

3.1.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Players (2020-2022)

3.1.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Players (2020-2022)

3.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Proprotein Convertase Subtilisin/Kexin Type 9 by Regions

4.1 Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Regions (2017-2022)

4.2 Americas Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth (2017-2022)

4.3 APAC Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth (2017-2022)

4.4 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth (2017-2022)

4.5 Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth (2017-2022)

5 Americas

5.1 Americas Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Country (2017-2022)

5.2 Americas Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Type (2017-2022)

5.3 Americas Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Region (2017-2022)

6.2 APAC Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Type (2017-2022)

6.3 APAC Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Proprotein Convertase Subtilisin/Kexin Type 9 by Country (2017-2022)

7.2 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Type (2017-2022)

7.3 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 by Region (2017-2022)

8.2 Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Type (2017-2022)

8.3 Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast

10.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Forecast by Regions (2023-2028)

10.1.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Forecast by Regions (2023-2028)

10.1.2 Americas Proprotein Convertase Subtilisin/Kexin Type 9 Forecast

10.1.3 APAC Proprotein Convertase Subtilisin/Kexin Type 9 Forecast

10.1.4 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Forecast

10.1.5 Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 Forecast

10.2 Americas Proprotein Convertase Subtilisin/Kexin Type 9 Forecast by Country (2023-2028)

10.2.1 United States Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast

10.2.2 Canada Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast

10.2.3 Mexico Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast

10.2.4 Brazil Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast

10.3 APAC Proprotein Convertase Subtilisin/Kexin Type 9 Forecast by Region (2023-2028)

10.3.1 China Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast

10.3.2 Japan Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast

10.3.3 Korea Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast

10.3.4 Southeast Asia Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast

10.3.5 India Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast

10.3.6 Australia Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast

10.4 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Forecast by Country (2023-2028)

10.4.1 Germany Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast

10.4.2 France Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast

10.4.3 UK Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast

10.4.4 Italy Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast

10.4.5 Russia Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast

10.5 Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 Forecast by Region (2023-2028)

10.5.1 Egypt Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast

10.5.2 South Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast

10.5.3 Israel Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast

10.5.4 Turkey Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast

10.5.5 GCC Countries Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast

10.6 Global Proprotein Convertase Subtilisin/Kexin Type 9 Forecast by Type (2023-2028)

10.7 Global Proprotein Convertase Subtilisin/Kexin Type 9 Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 AFFiRiS AG

11.1.1 AFFiRiS AG Company Information

11.1.2 AFFiRiS AG Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered

11.1.3 AFFiRiS AG Proprotein Convertase Subtilisin/Kexin Type 9 Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 AFFiRiS AG Main Business Overview

11.1.5 AFFiRiS AG Latest Developments

11.2 Betagenon AB

11.2.1 Betagenon AB Company Information

11.2.2 Betagenon AB Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered

11.2.3 Betagenon AB Proprotein Convertase Subtilisin/Kexin Type 9 Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Betagenon AB Main Business Overview

11.2.5 Betagenon AB Latest Developments

11.3 Bioleaders Corp

11.3.1 Bioleaders Corp Company Information

11.3.2 Bioleaders Corp Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered

11.3.3 Bioleaders Corp Proprotein Convertase Subtilisin/Kexin Type 9 Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Bioleaders Corp Main Business Overview

11.3.5 Bioleaders Corp Latest Developments

11.4 BioLingus AG

11.4.1 BioLingus AG Company Information

11.4.2 BioLingus AG Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered

11.4.3 BioLingus AG Proprotein Convertase Subtilisin/Kexin Type 9 Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 BioLingus AG Main Business Overview

11.4.5 BioLingus AG Latest Developments

11.5 Catabasis Pharmaceuticals Inc

11.5.1 Catabasis Pharmaceuticals Inc Company Information

11.5.2 Catabasis Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered

11.5.3 Catabasis Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Catabasis Pharmaceuticals Inc Main Business Overview

11.5.5 Catabasis Pharmaceuticals Inc Latest Developments

11.6 Dicerna Pharmaceuticals Inc

11.6.1 Dicerna Pharmaceuticals Inc Company Information

11.6.2 Dicerna Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered

11.6.3 Dicerna Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Dicerna Pharmaceuticals Inc Main Business Overview

11.6.5 Dicerna Pharmaceuticals Inc Latest Developments

11.7 Eli Lilly and Co

11.7.1 Eli Lilly and Co Company Information

11.7.2 Eli Lilly and Co Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered

11.7.3 Eli Lilly and Co Proprotein Convertase Subtilisin/Kexin Type 9 Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Eli Lilly and Co Main Business Overview

11.7.5 Eli Lilly and Co Latest Developments

11.8 Ensemble Therapeutics Corp

11.8.1 Ensemble Therapeutics Corp Company Information

11.8.2 Ensemble Therapeutics Corp Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered

11.8.3 Ensemble Therapeutics Corp Proprotein Convertase Subtilisin/Kexin Type 9 Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Ensemble Therapeutics Corp Main Business Overview

11.8.5 Ensemble Therapeutics Corp Latest Developments

11.9 Kowa Co Ltd

11.9.1 Kowa Co Ltd Company Information

11.9.2 Kowa Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered

11.9.3 Kowa Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Kowa Co Ltd Main Business Overview

11.9.5 Kowa Co Ltd Latest Developments

11.10 Novartis AG

11.10.1 Novartis AG Company Information

11.10.2 Novartis AG Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered

11.10.3 Novartis AG Proprotein Convertase Subtilisin/Kexin Type 9 Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Novartis AG Main Business Overview

11.10.5 Novartis AG Latest Developments

11.11 Pfizer Inc

11.11.1 Pfizer Inc Company Information

11.11.2 Pfizer Inc Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered

11.11.3 Pfizer Inc Proprotein Convertase Subtilisin/Kexin Type 9 Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Pfizer Inc Main Business Overview

11.11.5 Pfizer Inc Latest Developments

11.12 Regeneron Pharmaceuticals Inc

11.12.1 Regeneron Pharmaceuticals Inc Company Information

11.12.2 Regeneron Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered

11.12.3 Regeneron Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Regeneron Pharmaceuticals Inc Main Business Overview

11.12.5 Regeneron Pharmaceuticals Inc Latest Developments

11.13 Serometrix LLC

11.13.1 Serometrix LLC Company Information

11.13.2 Serometrix LLC Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered

11.13.3 Serometrix LLC Proprotein Convertase Subtilisin/Kexin Type 9 Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Serometrix LLC Main Business Overview

11.13.5 Serometrix LLC Latest Developments

11.14 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd

11.14.1 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Company Information

11.14.2 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered

11.14.3 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Main Business Overview

11.14.5 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Latest Developments

11.15 The Medicines Company

11.15.1 The Medicines Company Company Information

11.15.2 The Medicines Company Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered

11.15.3 The Medicines Company Proprotein Convertase Subtilisin/Kexin Type 9 Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 The Medicines Company Main Business Overview

11.15.5 The Medicines Company Latest Developments

12 Research Findings and Conclusion

Table 1. Proprotein Convertase Subtilisin/Kexin Type 9 Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of SX-PCK9

Table 3. Major Players of O-304

Table 4. Major Players of K-312

Table 5. Major Players of BLSM-201

Table 6. Major Players of DCRPCSK-9

Table 7. Major Players of Others

Table 8. Proprotein Convertase Subtilisin/Kexin Type 9 Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Type (2017-2022) & ($ Millions)

Table 10. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Type (2017-2022)

Table 11. Proprotein Convertase Subtilisin/Kexin Type 9 Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 12. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Application (2017-2022) & ($ Millions)

Table 13. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Application (2017-2022)

Table 14. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Players (2020-2022) & ($ Millions)

Table 15. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Player (2020-2022)

Table 16. Proprotein Convertase Subtilisin/Kexin Type 9 Key Players Head office and Products Offered

Table 17. Proprotein Convertase Subtilisin/Kexin Type 9 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 18. New Products and Potential Entrants

Table 19. Mergers & Acquisitions, Expansion

Table 20. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Regions 2017-2022 & ($ Millions)

Table 21. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Regions (2017-2022)

Table 22. Americas Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Country (2017-2022) & ($ Millions)

Table 23. Americas Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Country (2017-2022)

Table 24. Americas Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Type (2017-2022) & ($ Millions)

Table 25. Americas Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Type (2017-2022)

Table 26. Americas Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Application (2017-2022) & ($ Millions)

Table 27. Americas Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Application (2017-2022)

Table 28. APAC Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Region (2017-2022) & ($ Millions)

Table 29. APAC Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Region (2017-2022)

Table 30. APAC Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Type (2017-2022) & ($ Millions)

Table 31. APAC Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Type (2017-2022)

Table 32. APAC Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Application (2017-2022) & ($ Millions)

Table 33. APAC Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Application (2017-2022)

Table 34. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Country (2017-2022) & ($ Millions)

Table 35. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Country (2017-2022)

Table 36. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Type (2017-2022) & ($ Millions)

Table 37. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Type (2017-2022)

Table 38. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Application (2017-2022) & ($ Millions)

Table 39. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Application (2017-2022)

Table 40. Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Region (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Region (2017-2022)

Table 42. Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Type (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Type (2017-2022)

Table 44. Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Application (2017-2022) & ($ Millions)

Table 45. Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Application (2017-2022)

Table 46. Key Market Drivers & Growth Opportunities of Proprotein Convertase Subtilisin/Kexin Type 9

Table 47. Key Market Challenges & Risks of Proprotein Convertase Subtilisin/Kexin Type 9

Table 48. Key Industry Trends of Proprotein Convertase Subtilisin/Kexin Type 9

Table 49. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 50. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share Forecast by Regions (2023-2028)

Table 51. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 52. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share Forecast by Type (2023-2028)

Table 53. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 54. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share Forecast by Application (2023-2028)

Table 55. AFFiRiS AG Details, Company Type, Proprotein Convertase Subtilisin/Kexin Type 9 Area Served and Its Competitors

Table 56. AFFiRiS AG Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered

Table 57. AFFiRiS AG Proprotein Convertase Subtilisin/Kexin Type 9 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 58. AFFiRiS AG Main Business

Table 59. AFFiRiS AG Latest Developments

Table 60. Betagenon AB Details, Company Type, Proprotein Convertase Subtilisin/Kexin Type 9 Area Served and Its Competitors

Table 61. Betagenon AB Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered

Table 62. Betagenon AB Main Business

Table 63. Betagenon AB Proprotein Convertase Subtilisin/Kexin Type 9 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 64. Betagenon AB Latest Developments

Table 65. Bioleaders Corp Details, Company Type, Proprotein Convertase Subtilisin/Kexin Type 9 Area Served and Its Competitors

Table 66. Bioleaders Corp Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered

Table 67. Bioleaders Corp Main Business

Table 68. Bioleaders Corp Proprotein Convertase Subtilisin/Kexin Type 9 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 69. Bioleaders Corp Latest Developments

Table 70. BioLingus AG Details, Company Type, Proprotein Convertase Subtilisin/Kexin Type 9 Area Served and Its Competitors

Table 71. BioLingus AG Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered

Table 72. BioLingus AG Main Business

Table 73. BioLingus AG Proprotein Convertase Subtilisin/Kexin Type 9 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 74. BioLingus AG Latest Developments

Table 75. Catabasis Pharmaceuticals Inc Details, Company Type, Proprotein Convertase Subtilisin/Kexin Type 9 Area Served and Its Competitors

Table 76. Catabasis Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered

Table 77. Catabasis Pharmaceuticals Inc Main Business

Table 78. Catabasis Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 79. Catabasis Pharmaceuticals Inc Latest Developments

Table 80. Dicerna Pharmaceuticals Inc Details, Company Type, Proprotein Convertase Subtilisin/Kexin Type 9 Area Served and Its Competitors

Table 81. Dicerna Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered

Table 82. Dicerna Pharmaceuticals Inc Main Business

Table 83. Dicerna Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 84. Dicerna Pharmaceuticals Inc Latest Developments

Table 85. Eli Lilly and Co Details, Company Type, Proprotein Convertase Subtilisin/Kexin Type 9 Area Served and Its Competitors

Table 86. Eli Lilly and Co Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered

Table 87. Eli Lilly and Co Main Business

Table 88. Eli Lilly and Co Proprotein Convertase Subtilisin/Kexin Type 9 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 89. Eli Lilly and Co Latest Developments

Table 90. Ensemble Therapeutics Corp Details, Company Type, Proprotein Convertase Subtilisin/Kexin Type 9 Area Served and Its Competitors

Table 91. Ensemble Therapeutics Corp Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered

Table 92. Ensemble Therapeutics Corp Main Business

Table 93. Ensemble Therapeutics Corp Proprotein Convertase Subtilisin/Kexin Type 9 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 94. Ensemble Therapeutics Corp Latest Developments

Table 95. Kowa Co Ltd Details, Company Type, Proprotein Convertase Subtilisin/Kexin Type 9 Area Served and Its Competitors

Table 96. Kowa Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered

Table 97. Kowa Co Ltd Main Business

Table 98. Kowa Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 99. Kowa Co Ltd Latest Developments

Table 100. Novartis AG Details, Company Type, Proprotein Convertase Subtilisin/Kexin Type 9 Area Served and Its Competitors

Table 101. Novartis AG Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered

Table 102. Novartis AG Main Business

Table 103. Novartis AG Proprotein Convertase Subtilisin/Kexin Type 9 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. Novartis AG Latest Developments

Table 105. Pfizer Inc Details, Company Type, Proprotein Convertase Subtilisin/Kexin Type 9 Area Served and Its Competitors

Table 106. Pfizer Inc Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered

Table 107. Pfizer Inc Proprotein Convertase Subtilisin/Kexin Type 9 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 108. Pfizer Inc Main Business

Table 109. Pfizer Inc Latest Developments

Table 110. Regeneron Pharmaceuticals Inc Details, Company Type, Proprotein Convertase Subtilisin/Kexin Type 9 Area Served and Its Competitors

Table 111. Regeneron Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered

Table 112. Regeneron Pharmaceuticals Inc Main Business

Table 113. Regeneron Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 114. Regeneron Pharmaceuticals Inc Latest Developments

Table 115. Serometrix LLC Details, Company Type, Proprotein Convertase Subtilisin/Kexin Type 9 Area Served and Its Competitors

Table 116. Serometrix LLC Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered

Table 117. Serometrix LLC Main Business

Table 118. Serometrix LLC Proprotein Convertase Subtilisin/Kexin Type 9 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 119. Serometrix LLC Latest Developments

Table 120. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Details, Company Type, Proprotein Convertase Subtilisin/Kexin Type 9 Area Served and Its Competitors

Table 121. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered

Table 122. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Main Business

Table 123. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 124. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Latest Developments

Table 125. The Medicines Company Details, Company Type, Proprotein Convertase Subtilisin/Kexin Type 9 Area Served and Its Competitors

Table 126. The Medicines Company Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered

Table 127. The Medicines Company Main Business

Table 128. The Medicines Company Proprotein Convertase Subtilisin/Kexin Type 9 Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 129. The Medicines Company Latest Developments

List of Figures

Figure 1. Proprotein Convertase Subtilisin/Kexin Type 9 Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Type in 2021

Figure 7. Proprotein Convertase Subtilisin/Kexin Type 9 in Cardiovascular Disease

Figure 8. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market: Cardiovascular Disease (2017-2022) & ($ Millions)

Figure 9. Proprotein Convertase Subtilisin/Kexin Type 9 in Homozugous Familial Hyperchalesterolemia

Figure 10. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market: Homozugous Familial Hyperchalesterolemia (2017-2022) & ($ Millions)

Figure 11. Proprotein Convertase Subtilisin/Kexin Type 9 in Liver Disease

Figure 12. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market: Liver Disease (2017-2022) & ($ Millions)

Figure 13. Proprotein Convertase Subtilisin/Kexin Type 9 in Metabolic Syndrome

Figure 14. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market: Metabolic Syndrome (2017-2022) & ($ Millions)

Figure 15. Proprotein Convertase Subtilisin/Kexin Type 9 in Others

Figure 16. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market: Others (2017-2022) & ($ Millions)

Figure 17. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Application in 2021

Figure 18. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Player in 2021

Figure 19. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Regions (2017-2022)

Figure 20. Americas Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2017-2022 ($ Millions)

Figure 21. APAC Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2017-2022 ($ Millions)

Figure 22. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2017-2022 ($ Millions)

Figure 23. Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2017-2022 ($ Millions)

Figure 24. Americas Proprotein Convertase Subtilisin/Kexin Type 9 Value Market Share by Country in 2021

Figure 25. Americas Proprotein Convertase Subtilisin/Kexin Type 9 Consumption Market Share by Type in 2021

Figure 26. Americas Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Application in 2021

Figure 27. United States Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)

Figure 28. Canada Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)

Figure 29. Mexico Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)

Figure 30. Brazil Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)

Figure 31. APAC Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Region in 2021

Figure 32. APAC Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Application in 2021

Figure 33. China Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)

Figure 34. Japan Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)

Figure 35. Korea Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)

Figure 36. Southeast Asia Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)

Figure 37. India Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)

Figure 38. Australia Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)

Figure 39. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Country in 2021

Figure 40. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Type in 2021

Figure 41. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Application in 2021

Figure 42. Germany Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)

Figure 43. France Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)

Figure 44. UK Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)

Figure 45. Italy Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)

Figure 46. Russia Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)

Figure 47. Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Region in 2021

Figure 48. Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Type in 2021

Figure 49. Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Application in 2021

Figure 50. Egypt Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)

Figure 51. South Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)

Figure 52. Israel Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)

Figure 53. Turkey Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)

Figure 54. GCC Country Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)

Figure 55. Americas Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)

Figure 56. APAC Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)

Figure 57. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)

Figure 58. Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)

Figure 59. United States Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)

Figure 60. Canada Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)

Figure 61. Mexico Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)

Figure 62. Brazil Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)

Figure 63. China Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)

Figure 64. Japan Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)

Figure 65. Korea Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)

Figure 66. Southeast Asia Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)

Figure 67. India Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)

Figure 68. Australia Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)

Figure 69. Germany Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)

Figure 70. France Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)

Figure 71. UK Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)

Figure 72. Italy Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)

Figure 73. Russia Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)

Figure 74. Spain Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)

Figure 75. Egypt Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)

Figure 76. South Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)

Figure 77. Israel Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)

Figure 78. Turkey Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)

Figure 79. GCC Countries Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)